We are pleased to share a fantastic article by SelectScience®
Baroness Susan Greenfield CBE, neuroscientist and founder of Neuro-Bio, has spent four decades developing a novel hypothesis on the origins of Alzheimer’s disease.
Now, in collaboration with Aptamer Group, we are developing a first-of-its-kind diagnostic test using a unique biomarker and Aptamer’s Optimer binders. This inexpensive, non-invasive saliva test could detect Alzheimer’s up to 20 years before symptoms appear.
If successful, this breakthrough won’t just change how we detect Alzheimer’s – it could pave the way for preventative treatments and make this devastating disease a thing of the past.